Gene · 7031
Papers3,695
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,695
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell profiling reveals differences between human classical adenocarcinoma and mucinous adenocarcinoma. | Commun Biol | 2023 | 36690709 | PubTator, text mining | PubMed |
| CDK1 bridges NF-κB and β-catenin signaling in response to H. pylori infection in gastric tumorigenesis. | Cell Rep | 2023 | 36681899 | PubTator, text mining | PubMed |
| An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER+) Breast Cancer: Effects on Sensitive and Resistant Cell Lines. | Molecules | 2023 | 36677847 | PubTator, text mining | PubMed |
| Understanding the Clinical Significance of MUC5AC in Biliary Tract Cancers. | Cancers (Basel) | 2023 | 36672382 | PubTator, text mining | PubMed |
| Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping. | Nat Commun | 2023 | 36646721 | PubTator, text mining | PubMed |
| Ubiquitin-Specific Peptidase 8 Modulates Cell Proliferation and Induces Cell Cycle Arrest and Apoptosis in Breast Cancer by Stabilizing Estrogen Receptor Alpha. | J Oncol | 2023 | 36644233 | PubTator, text mining | PubMed |
| Inhibitors of Keap1-Nrf2 protein-protein interaction reduce estrogen responsive gene expression and oxidative stress in estrogen receptor-positive breast cancer. | Toxicol Appl Pharmacol | 2023 | 36634873 | PubTator, text mining | PubMed |
| The Landmark Series: Intraductal Papillary Mucinous Neoplasms of the Pancreas-From Prevalence to Early Cancer Detection. | Ann Surg Oncol | 2023 | 36600097 | PubTator, text mining | PubMed |
| The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options. | Cell Oncol (Dordr) | 2023 | 36598637 | PubTator, text mining | PubMed |
| Expression of trefoil factor 2 and 3 and adrenomedullin in chronic periodontitis subjects with coronary heart disease. | J Periodontol | 2023 | 36565448 | PubTator, text mining | PubMed |
| CDK8 and CDK19 act redundantly to control the CFTR pathway in the intestinal epithelium. | EMBO Rep | 2023 | 36545778 | PubTator, text mining | PubMed |
| Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor-Positive Breast Cancer. | Cancer Res | 2023 | 36469363 | PubTator, text mining | PubMed |
| Gastric cancer detection by non-blood-based liquid biopsies: A systematic review looking into the last decade of research. | United European Gastroenterol J | 2023 | 36461757 | PubTator, text mining | PubMed |
| Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity. | Cancer Res | 2023 | 36459568 | PubTator, text mining | PubMed |
| Establishment and characterization of adult human gastric epithelial progenitor-like cell lines. | Cell Prolif | 2023 | 36331058 | PubTator, text mining | PubMed |
| The ubiquitin ligase RNF2 stabilizes ERα and modulates breast cancer progression. | Hum Cell | 2023 | 36271315 | PubTator, text mining | PubMed |
| Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer. | Cancer Sci | 2023 | 36221793 | PubTator, text mining | PubMed |
| Modes of therapeutic delivery in synthetic microbiology. | Trends Microbiol | 2023 | 36220750 | PubTator, text mining | PubMed |
| Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn's Disease. | Inflamm Bowel Dis | 2023 | 36206201 | PubTator, text mining | PubMed |
| Tetrachlorobisphenol A and bisphenol AF induced cell migration by activating PI3K/Akt signaling pathway via G protein-coupled estrogen receptor 1 in SK-BR-3 cells. | Environ Toxicol | 2023 | 36190352 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7031/papers?page=19